Myocardium-derived conditioned medium improves left ventricular function in rodent acute myocardial infarction

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Biomedical Engineering

Background:

• Acute myocardial infarction (AMI) leads to significant left ventricular (LV) dysfunction.
• Preserving LV function post-AMI is crucial for patient outcomes.
• Novel therapeutic strategies are needed to mitigate myocardial damage.

Purpose of the Study:

• To evaluate the efficacy of myocardium-derived conditioned medium (MDCM) in preserving LV function in a rat AMI model.
• To investigate the effects of MDCM on cardiac fibrosis, angiogenesis, and oxidative stress post-AMI.

Main Methods:

• Adult male Sprague-Dawley rats underwent AMI induction or sham procedures.
• Animals were randomized into groups receiving fresh medium, normal MDCM, or infarct-related MDCM.
• MDCM or medium was administered via intramyocardial injection and subsequent intravenous injections.

Main Results:

• MDCM treatment in vitro reduced markers of fibrosis and increased factors associated with tissue repair.
• In vivo, infarct-related MDCM significantly reduced collagen deposition and oxidative stress in LV myocardium.
• MDCM therapy enhanced angiogenesis, indicated by increased vessel formation and higher stromal cell-derived factor-1α and CXCR4 expression.
• 90-day LV ejection fraction was significantly preserved in the MDCM-treated AMI group compared to controls.

Conclusions:

• Myocardium-derived conditioned medium (MDCM) therapy demonstrates significant potential in preserving cardiac function after AMI.
• MDCM effectively reduces cardiac fibrosis and oxidative stress, while promoting beneficial angiogenesis.
• This study supports MDCM as a promising therapeutic agent for myocardial infarction recovery.